Ciphergen Stock Loses Ground Gained on News of BioSepra Divestiture | GenomeWeb

This article has been updated from an earlier version to include stock quotes and details on the divestiture.

NEW YORK, Oct. 27 (GenomeWeb News) - Shares in Ciphergen lost some of the ground ground they gained early this afternoon on news that the company sold its BioSepra Process Division to Pall


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.